CNC
AZN icon

Citizens & Northern Corp’s AstraZeneca AZN Stock Holding History

Citizens & Northern Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,451
Closed -$213K – 119
2025
Q1 		$213K Buy
+1,451
New +$210K 0.06% 112

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citizens & Northern Corp's AZN Position: Q2 2025 in Review

Citizens & Northern Corp sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 1,451 shares — an estimated $213K sold.

Citizens & Northern Corp first reported a position in AZN in Q1 2025 and held it in 1 quarter. The position peaked at $213K in Q1 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Citizens & Northern Corp reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Citizens & Northern Corp sold 1,451 AstraZeneca shares in Q2 2025, an estimated $213K.
  • Citizens & Northern Corp first reported a position in AstraZeneca in Q1 2025 and held it in 1 quarter.
  • Citizens & Northern Corp's AstraZeneca position peaked at $213K in Q1 2025.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Citizens & Northern Corp's 13F filing for Q2 2025, filed 30 Jul 2025.